Profiel
Dr. Magali Taiel, MD, is a Chief Medical Officer at Gensight Biologics SA. Dr. Taiel was previously employed as a Vice President-Clinical Development by ProQR Therapeutics NV and a Project Manager by Servier SAS. She received her doctorate degree from Universite Paris Cite.
Actieve functies van Magali Taiel
| Bedrijven | Functie | Begin |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Hoofd Techniek/Wetenschap/O&O | 08-10-2019 |
Eerdere bekende functies van Magali Taiel
| Bedrijven | Functie | Einde |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01-09-2018 |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | 01-01-2001 |
Opleiding van Magali Taiel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
















